Hepatitis B Stocks List
Symbol | Grade | Name | % Change |
---|---|---|---|
ARWR | D | Arrowhead Research Corporation | -6.41 |
CBPO | C | China Biologic Products, Inc. | -0.22 |
DVAX | C | Dynavax Technologies Corporation | 3.34 |
IONS | F | Ionis Pharmaceuticals, Inc. | -3.01 |
SVA | F | Sinovac Biotech, Ltd. (Antigua/Barbudo) | 0.00 |
ABUS | F | Arbutus Biopharma Corporation | -1.82 |
BMY | F | Bristol-Myers Squibb Company | 0.03 |
AIM | D | AIM ImmunoTech Inc. | -1.95 |
INO | F | Inovio Pharmaceuticals, Inc. | -3.05 |
NNVC | C | NanoViricides, Inc. | -6.23 |
HEPA | F | Hepion Pharmaceuticals, Inc. | 1.61 |
BNTC | F | Benitec Biopharma Limited | 1.45 |
NTLA | D | Intellia Therapeutics, Inc. | -10.08 |
CODX | D | Co-Diagnostics, Inc. | 0.41 |
VXRT | F | Vaxart, Inc. | 0.25 |
HOOK | B | HOOKIPA Pharma Inc. | 1.55 |
VIR | D | Vir Biotechnology, Inc. | -6.15 |
GOVX | D | GeoVax Labs, Inc. | 7.59 |
ALGS | F | Aligos Therapeutics, Inc. | 3.17 |
SBTX | B | Silverback Therapeutics, Inc. | 6.34 |
Symbol | Grade | Name | Weight |
---|---|---|---|
NVQ | B | QRAFT AI-Enhanced US Next Value ETF | 8.61 |
GERM | F | ETFMG Treatments Testing and Advancements ETF | 8.45 |
FTXH | D | First Trust Nasdaq Pharmaceuticals ETF | 7.62 |
GNOM | D | Global X Genomics & Biotechnology ETF | 7.3 |
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 6.84 |
View all Hepatitis B related ETFs...
Compare ETFs
Date | Stock | Signal | Type |
---|---|---|---|
2021-03-08 | ABUS | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | ABUS | Slingshot Bearish | Bearish Swing Setup |
2021-03-08 | ABUS | Fell Below 200 DMA | Bearish |
2021-03-08 | AIM | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | ALGS | Stochastic Buy Signal | Bullish |
2021-03-08 | ALGS | Slingshot Bearish | Bearish Swing Setup |
2021-03-08 | ARWR | Lower Bollinger Band Walk | Weakness |
2021-03-08 | ARWR | Slingshot Bearish | Bearish Swing Setup |
2021-03-08 | ARWR | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | ARWR | Stochastic Buy Signal | Bullish |
2021-03-08 | BMY | 20 DMA Resistance | Bearish |
2021-03-08 | BMY | 200 DMA Resistance | Bearish |
2021-03-08 | BMY | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | BNTC | NR7 | Range Contraction |
2021-03-08 | BNTC | Narrow Range Bar | Range Contraction |
2021-03-08 | CBPO | Stochastic Reached Oversold | Weakness |
2021-03-08 | GOVX | 50 DMA Resistance | Bearish |
2021-03-08 | GOVX | Stochastic Buy Signal | Bullish |
2021-03-08 | GOVX | New Uptrend | Bullish |
2021-03-08 | HEPA | Spinning Top | Other |
2021-03-08 | HEPA | Bullish Engulfing | Bullish |
2021-03-08 | HOOK | Spinning Top | Other |
2021-03-08 | HOOK | 20 DMA Support | Bullish |
2021-03-08 | HOOK | Pocket Pivot | Bullish Swing Setup |
2021-03-08 | HOOK | Bollinger Band Squeeze | Range Contraction |
2021-03-08 | INO | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | INO | NR7 | Range Contraction |
2021-03-08 | INO | Narrow Range Bar | Range Contraction |
2021-03-08 | INO | Lower Bollinger Band Walk | Weakness |
2021-03-08 | IONS | Slingshot Bearish | Bearish Swing Setup |
2021-03-08 | IONS | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | NNVC | 200 DMA Support | Bullish |
2021-03-08 | NNVC | MACD Bearish Signal Line Cross | Bearish |
2021-03-08 | NNVC | Calm After Storm | Range Contraction |
2021-03-08 | NNVC | Fell Below 20 DMA | Bearish |
2021-03-08 | NTLA | Lower Bollinger Band Walk | Weakness |
2021-03-08 | NTLA | Stochastic Buy Signal | Bullish |
2021-03-08 | SBTX | 20 DMA Resistance | Bearish |
2021-03-08 | SBTX | Crossed Above 50 DMA | Bullish |
2021-03-08 | SBTX | Expansion Pivot Buy Setup | Bullish Swing Setup |
2021-03-08 | VIR | Narrow Range Bar | Range Contraction |
2021-03-08 | VIR | Calm After Storm | Range Contraction |
2021-03-08 | VIR | NR7 | Range Contraction |
2021-03-08 | VIR | 180 Bearish Setup | Bearish Swing Setup |
2021-03-08 | VIR | Lower Bollinger Band Walk | Weakness |
Hepatitis B is an infectious disease caused by the hepatitis B virus (HBV) that affects the liver. It can cause both acute and chronic infections. Many people have no symptoms during the initial infection. Some develop a rapid onset of sickness with vomiting, yellowish skin, tiredness, dark urine and abdominal pain. Often these symptoms last a few weeks and rarely does the initial infection result in death. It may take 30 to 180 days for symptoms to begin. In those who get infected around the time of birth 90% develop chronic hepatitis B while less than 10% of those infected after the age of five do. Most of those with chronic disease have no symptoms; however, cirrhosis and liver cancer may eventually develop. These complications result in the death of 15 to 25% of those with chronic disease.The virus is transmitted by exposure to infectious blood or body fluids. Infection around the time of birth or from contact with other people's blood during childhood is the most frequent method by which hepatitis B is acquired in areas where the disease is common. In areas where the disease is rare, intravenous drug use and sexual intercourse are the most frequent routes of infection. Other risk factors include working in healthcare, blood transfusions, dialysis, living with an infected person, travel in countries where the infection rate is high, and living in an institution. Tattooing and acupuncture led to a significant number of cases in the 1980s; however, this has become less common with improved sterility. The hepatitis B viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. The infection can be diagnosed 30 to 60 days after exposure. The diagnosis is usually confirmed by testing the blood for parts of the virus and for antibodies against the virus. It is one of five main hepatitis viruses: A, B, C, D, and E.The infection has been preventable by vaccination since 1982. Vaccination is recommended by the World Health Organization in the first day of life if possible. Two or three more doses are required at a later time for full effect. This vaccine works about 95% of the time. About 180 countries gave the vaccine as part of national programs as of 2006. It is also recommended that all blood be tested for hepatitis B before transfusion and condoms be used to prevent infection. During an initial infection, care is based on the symptoms that a person has. In those who develop chronic disease, antiviral medication such as tenofovir or interferon may be useful; however, these drugs are expensive. Liver transplantation is sometimes used for cirrhosis.About a third of the world population has been infected at one point in their lives, including 343 million who have chronic infections. Another 129 million new infections occurred in 2013. Over 750,000 people die of hepatitis B each year. About 300,000 of these are due to liver cancer. The disease is now only common in East Asia and sub-Saharan Africa where between 5 and 10% of adults are chronically infected. Rates in Europe and North America are less than 1%. It was originally known as "serum hepatitis". Research is looking to create foods that contain HBV vaccine. The disease may affect other great apes as well.
Mike's Notes
- TWLO: Here's anoth...
- ABNB: An interesti...
- CGNT: Not a chart ...
- TDOC: One of sever...
- NFLX: I love these...
From the Blog
Popular Now
Featured Articles
- What You Trade Is As Important As How You Trade
- Breakouts, Home Runs & Exponential Returns w/ Kristjan Kullamägi
- Tech Stock Indices: Do Bulls Have A Problem?
- Robinhood Proxies – The Private and Public Markets Can Be Very Connected
- The Rise of Cult Stocks
- Semi-automating Your Trading
- Recommended Stock Trading Books